📣Register now for the third webinar of the program “EDITSCD & ERN-EuroBloodNet: Focus on Genetic Therapy for People Living with Sickle Cell Disease.”
Join us to better understand how innovative therapies are moving from lab to clinic!
Register now: https://t.co/66o7wDxS85
And here it is our last work on Base editing of β0-thalassemia mutations with a nice online cover by Science Translational Medicine!
Thank you to @LabMiccio@Inserm@Imagine Institute and to all our collaborators @marioamendola1
https://t.co/8jRMAwXJQe
And here it is our last work on Base editing of β0-thalassemia mutations with a nice online cover by Science Translational Medicine!
Thank you to @LabMiccio@Inserm@Imagine Institute and to all our collaborators @marioamendola1
https://t.co/8jRMAwXJQe
This week's issue of #ScienceTranslationalMedicine has arrived!
A transcriptional signature could inform smarter antibiotic use in newborns with sepsis, an approved medication boosts anti-malaria immunity in volunteers, and more. https://t.co/CUa69kYEYd
This week's issue of #ScienceTranslationalMedicine has arrived!
A transcriptional signature could inform smarter antibiotic use in newborns with sepsis, an approved medication boosts anti-malaria immunity in volunteers, and more. https://t.co/CUa69kYEYd
A huge thank-you to Guillermo Montoya (@g1_guillermo), Marcello Maresca, Angelo Lombardo, and Toni Cathomen for sharing this adventure as co-organizers — and to all the speakers, presenters and sponsors for making it all possible!
See you in 2025! 🎉
It was amazing to host so many brilliant researchers — along with passionate young scientists — in Sorrento, Italy, for the EMBO Workshop “CRISPR-Cas: From Biology to Therapeutic Applications.#EMBOCRISPRcas
An exciting year for our lab, epigenome , prime editing and now the elegant work by led by Letizia Fontana and Panagiotis Antoniou on multiplex base editing:
https://t.co/Pst4DkoPxl
Thanks also to Oriana Romano and @marioamendola1 Mario Amendola for the great collaboration!
Happy to share our recent work led by @MeganeBrusson in our lab and just published in Blood describing a prime editing strategy to reactivate fetal hemoglobin for sickle cell disease
https://t.co/avJadIwAUE
Congrats to Megane, all the lab members and our collaborators!
Happy to share our work published today on Nucleic Acid Research @NAR_Open :
"Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies"
https://t.co/qJw5ygxOS5